Zhiyong Chen

机构：Central South University, Hunan University, Longyan University, Nanfang Hospital, Cidara Therapeutics (United States), Guangdong Academy of Medical Sciences, Southern Medical University · ORCID：0000-0001-5032-8280

发表论文 96 篇 · 总被引 1097 次 · h-index 18

代表论文

• Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients (2023 · Cancer Cell · 被引 101)
• An alternatingly amphiphilic, resistance-resistant antimicrobial oligoguanidine with dual mechanisms of action (2021 · Biomaterials · 被引 60)
• Lifestyle factors, serum parameters, metabolic comorbidities, and the risk of kidney stones: a Mendelian randomization study (2023 · Frontiers in Endocrinology · 被引 44)
• Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104) (2024 · Cell Reports Medicine · 被引 38)
• PER2 integrates circadian disruption and pituitary tumorigenesis (2023 · Theranostics · 被引 34)
• Potentiation of Vancomycin: Creating Cooperative Membrane Lysis through a “Derivatization-for-Sensitization” Approach (2022 · Journal of the American Chemical Society · 被引 34)